Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.12
Twist Bioscience Sees Q1 Sales $130.000M-$132.000M vs $126.354M Est
Benzinga
2026.11.12
Chevron To Restart Operations At Its Biodiesel Production Facility In Ralston, Iowa, With Capacity Of Almost 42M Gallons/Year
Benzinga
2026.11.12
Canaccord Genuity Maintains Buy on HIVE Digital Technologies, Lowers Price Target to $6
Benzinga
2026.11.12
PLAYSTUDIOS Commences Modified Dutch Auction Tender Offer To Purchase For Cash Up To $15M Of Its Outstanding Class A Shares
Benzinga
2026.11.12
Cardiff Oncology Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $171.000K Beat $67.857K Estimate
Benzinga
2026.11.12
Baird Maintains Neutral on Tetra Tech, Raises Price Target to $40
Benzinga
2026.11.12
Mobility Global Affirms FY2026 Sales Guidance of $1.870B-$1.885B vs $1.876B Est
Benzinga
2026.11.12
Baird Maintains Outperform on ITG, Lowers Price Target to $10
Benzinga
2026.11.12
Arcos Dorados Holdings Q3 EPS $0.15 Beats $0.14 Estimate, Sales $1.328B Beat $1.320B Estimate
Benzinga
2026.11.12
Octave Intelligence Q3 Adj. EPS $0.32, Inline, Sales $415.000M Beat $401.940M Estimate
Benzinga
2026.11.12
TScan Therapeutics Q3 EPS $(0.25) Misses $(0.19) Estimate, Sales $586.000K Beat $459.000K Estimate
Benzinga
2026.11.12
Baird Maintains Neutral on InMode, Lowers Price Target to $15
Benzinga
2026.11.12
Nebius Group Sees FY2027 Sales $12.000B-$13.000B vs $11.976B Est
Benzinga
2026.11.12
Stratasys Q3 Adj. EPS $0.04 Beats $0.02 Estimate, Sales $142.640M Beat $141.919M Estimate
Benzinga
2026.11.12
UPDATE: Mobility Global Q3 Adj. EPS $0.40 Beats $0.38 Estimate
Benzinga
2026.11.12
Nebius Group Affirms FY2026 Sales Guidance of $3.000B-$3.400B vs $3.372B Est
Benzinga
2026.11.12
Cantor Fitzgerald Maintains Neutral on Coincheck Group, Lowers Price Target to $1.8
Benzinga
2026.11.12
Baird Maintains Outperform on Alcon, Lowers Price Target to $87
Benzinga
2026.11.12
Bristol Myers Squibb Appoints Cristian Massacesi To Lead A Unified, End-To-End R&D Organization, Effective January 1, 2027
Benzinga
2026.11.12
Medical Facilities Q3 EPS $0.28 Beats $0.12 Estimate, Sales $65.871M Beat $62.600M Estimate
Benzinga
2026.11.12
Cantor Fitzgerald Maintains Overweight on Etoro Group, Lowers Price Target to $37
Benzinga
2026.11.12
Traws Pharma Reports Final Phase 2a COVID-19 Data, Advances Influenza Candidate
Benzinga
2026.11.12
Fermi Announces Multiple New Agreements With Investment-Grade Hyperscaler To Advance 600 Megawatts Of Power Capacity At Project Matador
Benzinga
2026.11.12
Parabilis Medicines Q3 EPS $(0.36), Inline, Sales $2.114M Beat $375.000K Estimate
Benzinga
2026.11.12
Cantor Fitzgerald Maintains Overweight on Exodus Movement, Raises Price Target to $16
Benzinga
2026.11.12
Absci Q3 EPS $(0.19) Beats $(0.20) Estimate, Sales $304.000K Miss $727.125K Estimate
Benzinga
2026.11.12
President Trump, In Truth Post, Threatens to Immediately Double Tariffs on Mexico Unless It Stops Migrant Caravans
Benzinga
2026.11.12
Auxly Cannabis Group Q3 EPS $0.09 Down From $0.13 YoY, Sales $35.359M Up From $28.511M YoY
Benzinga
2026.11.12
JD.com Completes Voluntary Public Takeover Offer For CECONOMY, Acquiring 59.8% Of Share Capital And Voting Rights Of CECONOMY With Total Consideration Of EUR 1,335 Mln
Benzinga
2026.11.12
ProQR Therapeutics Q3 EPS $(0.10) Beats $(0.11) Estimate, Sales $5.933M Beat $5.350M Estimate
Benzinga
1
...
61
62
63
64
65
66
...
712
>